View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
Ropack|8 October 2021

Blister Packaging

Ropack has the technology - including serialization - capacity and human capital for leading-edge blister packaging.

Blister is a popular and growing packaging option worldwide, driven by its unique ability to provide increased product protection, improved patient compliance and precise dose accuracy. As blister becomes the global packaging of choice for many Rx and OTC products, industry leaders turn to us.

Our fully integrated blister line (Uhlmann, BEC 300) can serialize, package and carton.

Seven lines, including a fully intergreated Ulhmann BEC 300 with inline cartonning, banding, case packing and serialization.

Ropack is well-positionned to meet the demand for blister:

  • Serialization, including a unique International Serialization Hub
  • Seven blister lines
  • In house tooling design and manufacturing to reduce cost and leadtime
  • More than 6 000 tooling parts in inventory

Key packaging and safety features of Ropack blister:

  • Thermoformed using single and multilayer structures (PVC, PVdC, PE, PCTFE)
  • Cold formed using Alu/Alu
  • Highest quality barrier film for moisture and oxygen protection
  • Barcodes on back for compliance
  • Imprinting on back, random print, unit dose print with register
  • Electronic vision system and on-line monitoring devices
  • Senior-friendly and child-resistant blisters
  • Folding wallet cards for sampling or added marketing and client communication

Ropack's Paul Dupont explains how growing trends in the consumer healthcare industry signal promising market opportunities for leading nutraceutical and pharmaceutical companies.
Stickpack packaging in single-dose is globally accepted for its accuracy, convenience and cost savings.
Blister packaging, not long ago considered a less significant segment of the North American pharmaceutical packaging industry, is now outpacing most other industry segments.
The expanding global pharmaceutical industry projects a 4%-6% annual growth and forecasts that it will reach a value of $1 trillion by 2014.
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy